• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牙龈成纤维细胞与药物相关性颌骨坏死:实时和体外伤口愈合试验的结果。

Gingival fibroblasts and medication-related osteonecrosis of the jaw: Results by real-time and wound healing in vitro assays.

机构信息

Department of Oral and Maxillofacial Surgery, University Hospital Tuebingen, Osianderstr 2-8, 72076, Tübingen, Germany.

出版信息

J Craniomaxillofac Surg. 2019 Sep;47(9):1464-1474. doi: 10.1016/j.jcms.2019.06.004. Epub 2019 Jun 8.

DOI:10.1016/j.jcms.2019.06.004
PMID:31327558
Abstract

OBJECTIVE

This study investigated the effects of bisphosphonates and denosumab on human gingival fibroblasts (HGFs) that could influence inflammation, wound healing, and angiogenesis in medication-related osteonecrosis of the jaw (MRONJ).

METHODS

A real-time in vitro assay was performed on HGFs with and without the addition of bacterial lipopolysaccharide and a mononuclear cell co-culture to observe the effects of zoledronate, ibandronate, alendronate, clodronate, denosumab, and combinations of zoledronate and denosumab at varied concentrations. A wound healing assay was performed, and gene and protein expression was analyzed for inflammatory, angiogenic, and osteoclastogenic cytokines and mediators including interleukin (IL)-1β, IL-6, tumor necrosis factor alpha (TNFα), IL-8, vascular endothelial growth factor (VEGF), RANKL, and osteoprotegerin.

RESULTS

Higher concentrations of antiresorptives resulted in impaired wound healing and HGF death, which also occurred without mechanical damage. These effects were increased with bacterial lipopolysaccharide and mononuclear cells. Increased levels of IL-1β, TNFα, IL-8, VEGF, osteoprotegerin, and decreased levels of IL-6 were observed.

CONCLUSIONS

Antiresorptive exposure was associated with HGF death and delayed wound healing, which could be attributed to an elevated inflammatory response and immune dysfunction contributing to MRONJ development. There was no evidence of anti-angiogenic effects. Our experiments present the first results of denosumab with HGFs.

摘要

目的

本研究探讨了双膦酸盐和地舒单抗对人牙龈成纤维细胞(HGFs)的影响,这些影响可能会影响药物相关性颌骨骨坏死(MRONJ)中的炎症、伤口愈合和血管生成。

方法

在加入细菌脂多糖和单核细胞共培养的情况下,对 HGFs 进行实时体外检测,以观察唑来膦酸、伊班膦酸、阿仑膦酸、氯膦酸、地舒单抗以及唑来膦酸和地舒单抗的不同浓度组合的作用。进行伤口愈合检测,并分析炎症、血管生成和破骨细胞生成细胞因子和介质的基因和蛋白表达,包括白细胞介素(IL)-1β、IL-6、肿瘤坏死因子α(TNFα)、IL-8、血管内皮生长因子(VEGF)、RANKL 和骨保护素。

结果

更高浓度的抗吸收剂会导致伤口愈合受损和 HGF 死亡,即使没有机械损伤也会发生这种情况。这些影响随着细菌脂多糖和单核细胞的增加而增加。观察到 IL-1β、TNFα、IL-8、VEGF、骨保护素水平升高,IL-6 水平降低。

结论

抗吸收剂暴露与 HGF 死亡和伤口愈合延迟有关,这可能归因于炎症反应和免疫功能障碍的增加,导致 MRONJ 的发展。没有证据表明有抗血管生成作用。我们的实验首次提供了地舒单抗与 HGFs 作用的结果。

相似文献

1
Gingival fibroblasts and medication-related osteonecrosis of the jaw: Results by real-time and wound healing in vitro assays.牙龈成纤维细胞与药物相关性颌骨坏死:实时和体外伤口愈合试验的结果。
J Craniomaxillofac Surg. 2019 Sep;47(9):1464-1474. doi: 10.1016/j.jcms.2019.06.004. Epub 2019 Jun 8.
2
Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.低水平激光疗法通过 IL-1RA 介导的原发性牙龈创面愈合预防药物相关性颌骨样骨坏死性病变。
BMC Oral Health. 2023 Jan 10;23(1):14. doi: 10.1186/s12903-022-02678-1.
3
Exosomes Derived from Adipose Tissue-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw through IL-1RA.脂肪组织来源的间充质干细胞衍生的外泌体通过白细胞介素 1 受体拮抗剂预防药物相关性颌骨坏死。
Int J Mol Sci. 2023 May 12;24(10):8694. doi: 10.3390/ijms24108694.
4
Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.药物相关性颌骨坏死的组织学分析与抗吸收药物暴露性骨及其他感染性、炎症性和坏死性颌骨疾病的比较。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Feb;129(2):133-140. doi: 10.1016/j.oooo.2019.08.018. Epub 2019 Sep 3.
5
The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells.臭氧处理对应用双膦酸盐的人牙龈成纤维细胞中遗传毒性损伤和伤口愈合的影响。
Clin Oral Investig. 2018 Mar;22(2):867-873. doi: 10.1007/s00784-017-2163-6. Epub 2017 Jul 11.
6
Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.拔牙后进行一期伤口缝合以预防接受地诺单抗治疗患者的药物相关性颌骨坏死
Clin Oral Investig. 2017 Jan;21(1):127-134. doi: 10.1007/s00784-016-1762-y. Epub 2016 Feb 29.
7
[Position paper on medication-related osteonecrosis of the jaw (MRONJ)].[关于药物性颌骨坏死(MRONJ)的立场文件]
Wien Med Wochenschr. 2016 Feb;166(1-2):68-74. doi: 10.1007/s10354-016-0437-2.
8
Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.颌骨骨坏死:双膦酸盐类型、局部浓度及酸性环境对发病机制的影响
J Oral Maxillofac Surg. 2010 Nov;68(11):2837-45. doi: 10.1016/j.joms.2010.07.017.
9
Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.接受非手术牙周治疗后发生的地舒单抗相关性颌骨坏死:病例报告。
J Clin Periodontol. 2018 May;45(5):570-577. doi: 10.1111/jcpe.12882. Epub 2018 Apr 16.
10
Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).唑来膦酸而非地诺单抗可抑制THP-1细胞的巨噬细胞分化。双膦酸盐相关颌骨坏死(BRONJ)的病因模型。
Clin Oral Investig. 2015 Jul;19(6):1307-18. doi: 10.1007/s00784-014-1358-3. Epub 2014 Nov 21.

引用本文的文献

1
Alterations of bone proteins in medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死中骨蛋白的改变
Eur J Oral Sci. 2025 Apr;133(2):e70003. doi: 10.1111/eos.70003. Epub 2025 Feb 19.
2
The dynamin inhibitor, dynasore, prevents zoledronate-induced viability loss in human gingival fibroblasts by partially blocking zoledronate uptake and inhibiting endosomal acidification.动力蛋白抑制剂dynasore通过部分阻断唑来膦酸摄取并抑制内体酸化,防止唑来膦酸诱导的人牙龈成纤维细胞活力丧失。
J Appl Oral Sci. 2024 Sep 30;32:e20240224. doi: 10.1590/1678-7757-2024-0224. eCollection 2024.
3
Autologous platelet concentrates as adjuvant in the surgical management of medication-related osteonecrosis of the jaw.
自体血小板浓缩物作为颌骨药物相关性骨坏死外科治疗的辅助手段
Periodontol 2000. 2025 Feb;97(1):287-307. doi: 10.1111/prd.12608. Epub 2024 Sep 30.
4
Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.药物相关性下颌骨坏死(MRONJ):发病机制假说和治疗策略的综述。
Arch Toxicol. 2024 Mar;98(3):689-708. doi: 10.1007/s00204-023-03653-7. Epub 2023 Dec 28.
5
Alendronate reduces periosteal microperfusion in vivo.阿仑膦酸盐可降低体内骨膜微灌注。
Heliyon. 2023 Aug 25;9(9):e19468. doi: 10.1016/j.heliyon.2023.e19468. eCollection 2023 Sep.
6
Oral fibroblasts rescue osteogenic differentiation of mesenchymal stem cells after exposure to Zoledronic acid in a paracrine effect.口腔成纤维细胞通过旁分泌作用挽救暴露于唑来膦酸后间充质干细胞的成骨分化。
Front Pharmacol. 2023 Aug 11;14:1172705. doi: 10.3389/fphar.2023.1172705. eCollection 2023.
7
Increased apoptosis of gingival epithelium is associated with impaired autophagic flux in medication-related osteonecrosis of the jaw.药物相关性颌骨骨坏死中牙龈上皮细胞凋亡增加与自噬流受损有关。
Autophagy. 2023 Nov;19(11):2899-2911. doi: 10.1080/15548627.2023.2234228. Epub 2023 Jul 21.
8
In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review.抗吸收和抗血管生成化合物对口腔组织的体外细胞毒性与 MRONJ 有关:系统评价。
Biomolecules. 2023 Jun 10;13(6):973. doi: 10.3390/biom13060973.
9
Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.抗血管生成药物通过损害牙龈成纤维细胞的增殖和迁移功能,加重了基于抗吸收药物的药物相关性颌骨坏死的程度。
BMC Oral Health. 2023 May 27;23(1):330. doi: 10.1186/s12903-023-03034-7.
10
Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw.β-磷酸三钙单独使用或联合使用抗菌光动力疗法或强力霉素可预防药物相关性颌骨坏死。
Sci Rep. 2022 Oct 3;12(1):16510. doi: 10.1038/s41598-022-20128-4.